AI assistant
Sending…
InspireMD, Inc. — Director's Dealing 2025
Jul 23, 2025
34187_dirs_2025-07-23_03e336e2-25f4-49be-92d3-f82506a077f2.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: InspireMD, Inc. (NSPR)
CIK: 0001433607
Period of Report: 2025-07-11
Reporting Person: Kester Thomas J (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-07-11 | Common Stock | X | 30624 | $1.3827 | Acquired | 389767 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2025-07-11 | Series I Warrant (right to buy) | $1.3827 | X | 30624 | Disposed | 2025-07-23 | Common Stock (30624) | Direct |
More from InspireMD, Inc.
Declaration of Voting Results & Voting Rights Announcements
2026
Jun 3
Board/Management Information
2026
May 22
Interim / Quarterly Report
2026
May 7
Annual Report
2026
Apr 20
Capital/Financing Update
2026
Apr 3
Capital/Financing Update
2026
Apr 3
Annual Report
2026
Mar 18
Major Shareholding Notification
2026
Feb 17
Major Shareholding Notification
2026
Feb 11
Major Shareholding Notification
2026
Feb 2